Yesterday, the Wall Street Journal addressed two early stage drug studies- one from Bristrol-Myers Squibb and one from Roche Holding AG. Both drug studies rely on the power of the patients’ immune system to fight the cancer they have been … Continue reading →

A 9 year old from Redmond, OR with acute lymphoblastic leukemia is in remission after receiving an experimental modified T cell treatment, according to a post on her father’s Facebook page.  Similar to the results previously published by Stephan Grupp … Continue reading →

Multiple sclerosis (MS) is considered to be an autoimmune disease, but the trigger for the onset of the disease is not known. Recent results on treatment with anti- CD20 antibodies has shown B-cell depletion, implying a central role for Bcells. It has also … Continue reading →

An interesting paper was recently published in Nature. This is not directly related to adaptive immunology but the points they emphasize towards the end of the article might give an immunologist reason to pause. “The findings further undermine the idea that common diseases are … Continue reading →

Although the article was published online about 2 months ago, the physical issue of Science on July 6th 2012 featured a research article “Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes” for which Dr. Mark Rieder, … Continue reading →

Yesterday, an article in Nature was published online on Cancer Detection, called “Sequencing spots tumour cells“. This article describes Harlan Robin’s findings from our most recently published paper on MRD. Although the full article is only available for free to subscribers, … Continue reading →